Literature DB >> 24116943

AAV2/8 vectors purified from culture medium with a simple and rapid protocol transduce murine liver, muscle, and retina efficiently.

Monica Doria1, Antonella Ferrara, Alberto Auricchio.   

Abstract

During the production of some adeno-associated virus (AAV) serotypes, a large amount of vectors is found in the medium of producing cells. For their purification, previous protocols used tangential flow filtration (TFF) of the medium followed by iodixanol gradient centrifugation. Taking advantage of the higher purity of the medium than the cell-derived material as the source of AAV, we tested a simple method that combines production of large culture medium volumes containing AAV from cell stacks with medium clarification+TFF without further time-consuming and nonscalable centrifugation. To test this, we selected AAV2/8, which is emerging as a favored serotype for transduction of liver, muscle, and retina and abundantly found in the extracellular medium. We show that yields and in vitro infectivity of AAV2/8 vectors produced from the culture medium using this method are higher than those of vectors purified from the same cell lysate using a conventional CsCl2 gradient ultracentrifugation-based method, although purity appears inferior. In addition, we found that the transduction efficiency of AAV2/8 purified from medium was similar to that of AAV2/8 purified from the same cell lysate in the murine liver, muscle, and retina. Considering that the purification protocol from the medium we describe requires 3 hr as opposed to the 63 hr of a conventional two-round CsCl2-gradient ultracentrifugation+desalting, we conclude that TFF of the medium containing AAV2/8 represents a quick and scalable method to purify research-grade vectors for use in animal models.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24116943      PMCID: PMC3869536          DOI: 10.1089/hgtb.2013.155

Source DB:  PubMed          Journal:  Hum Gene Ther Methods        ISSN: 1946-6536            Impact factor:   2.396


  25 in total

1.  Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield.

Authors:  S Zolotukhin; B J Byrne; E Mason; I Zolotukhin; M Potter; K Chesnut; C Summerford; R J Samulski; N Muzyczka
Journal:  Gene Ther       Date:  1999-06       Impact factor: 5.250

2.  CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells.

Authors:  Y Zhang; N Chirmule; G p Gao; J Wilson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Intraocular delivery of recombinant virus.

Authors:  F Q Liang; V Anand; A M Maguire; J Bennett
Journal:  Methods Mol Med       Date:  2001

4.  Factors influencing recombinant adeno-associated virus production.

Authors:  A Salvetti; S Orève; G Chadeuf; D Favre; Y Cherel; P Champion-Arnaud; J David-Ameline; P Moullier
Journal:  Hum Gene Ther       Date:  1998-03-20       Impact factor: 5.695

Review 5.  Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients.

Authors:  Pasqualina Colella; Alberto Auricchio
Journal:  Hum Gene Ther       Date:  2012-08       Impact factor: 5.695

6.  Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions.

Authors:  C Summerford; R J Samulski
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency.

Authors:  E Ayuso; F Mingozzi; J Montane; X Leon; X M Anguela; V Haurigot; S A Edmonson; L Africa; S Zhou; K A High; F Bosch; J F Wright
Journal:  Gene Ther       Date:  2009-12-03       Impact factor: 5.250

8.  Scalable purification of adeno-associated virus serotype 1 (AAV1) and AAV8 vectors, using dual ion-exchange adsorptive membranes.

Authors:  Takashi Okada; Mutsuko Nonaka-Sarukawa; Ryosuke Uchibori; Kazue Kinoshita; Hiromi Hayashita-Kinoh; Yuko Nitahara-Kasahara; Shin'ichi Takeda; Keiya Ozawa
Journal:  Hum Gene Ther       Date:  2009-09       Impact factor: 5.695

9.  Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.

Authors:  Guang-Ping Gao; Mauricio R Alvira; Lili Wang; Roberto Calcedo; Julie Johnston; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

10.  Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column.

Authors:  A Auricchio; M Hildinger; E O'Connor; G P Gao; J M Wilson
Journal:  Hum Gene Ther       Date:  2001-01-01       Impact factor: 5.695

View more
  22 in total

Review 1.  BAR-Seq clonal tracking of gene-edited cells.

Authors:  Samuele Ferrari; Stefano Beretta; Aurelien Jacob; Davide Cittaro; Luisa Albano; Ivan Merelli; Luigi Naldini; Pietro Genovese
Journal:  Nat Protoc       Date:  2021-05-24       Impact factor: 13.491

2.  Copackaging of multiple adeno-associated viral vectors in a single production step.

Authors:  Phillip A Doerfler; Barry J Byrne; Nathalie Clément
Journal:  Hum Gene Ther Methods       Date:  2014-09-19       Impact factor: 2.396

3.  Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo.

Authors:  Bence György; Zachary Fitzpatrick; Matheus H W Crommentuijn; Dakai Mu; Casey A Maguire
Journal:  Biomaterials       Date:  2014-06-07       Impact factor: 12.479

4.  Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors.

Authors:  Amine Meliani; Florence Boisgerault; Zachary Fitzpatrick; Solenne Marmier; Christian Leborgne; Fanny Collaud; Marcelo Simon Sola; Severine Charles; Giuseppe Ronzitti; Alban Vignaud; Laetitia van Wittenberghe; Beatrice Marolleau; Fabienne Jouen; Sisareuth Tan; Olivier Boyer; Olivier Christophe; Alain R Brisson; Casey A Maguire; Federico Mingozzi
Journal:  Blood Adv       Date:  2017-10-16

5.  Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina.

Authors:  Patrizia Tornabene; Ivana Trapani; Renato Minopoli; Miriam Centrulo; Mariangela Lupo; Sonia de Simone; Paola Tiberi; Fabio Dell'Aquila; Elena Marrocco; Carolina Iodice; Antonella Iuliano; Carlo Gesualdo; Settimio Rossi; Laura Giaquinto; Silvia Albert; Carel B Hoyng; Elena Polishchuk; Frans P M Cremers; Enrico M Surace; Francesca Simonelli; Maria A De Matteis; Roman Polishchuk; Alberto Auricchio
Journal:  Sci Transl Med       Date:  2019-05-15       Impact factor: 19.319

6.  Therapeutic homology-independent targeted integration in retina and liver.

Authors:  Patrizia Tornabene; Rita Ferla; Manel Llado-Santaeularia; Miriam Centrulo; Margherita Dell'Anno; Federica Esposito; Elena Marrocco; Emanuela Pone; Renato Minopoli; Carolina Iodice; Edoardo Nusco; Settimio Rossi; Hristiana Lyubenova; Anna Manfredi; Lucio Di Filippo; Antonella Iuliano; Annalaura Torella; Giulio Piluso; Francesco Musacchia; Enrico Maria Surace; Davide Cacchiarelli; Vincenzo Nigro; Alberto Auricchio
Journal:  Nat Commun       Date:  2022-04-12       Impact factor: 17.694

7.  Simple downstream process based on detergent treatment improves yield and in vivo transduction efficacy of adeno-associated virus vectors.

Authors:  Gabriella Dias Florencio; Guillaume Precigout; Cyriaque Beley; Pierre-Olivier Buclez; Luis Garcia; Rachid Benchaouir
Journal:  Mol Ther Methods Clin Dev       Date:  2015-07-15       Impact factor: 6.698

8.  High-Throughput Screening Identifies Kinase Inhibitors That Increase Dual Adeno-Associated Viral Vector Transduction In Vitro and in Mouse Retina.

Authors:  Andrea Maddalena; Fabio Dell'Aquila; Pia Giovannelli; Paola Tiberi; Luca Giorgio Wanderlingh; Sandro Montefusco; Patrizia Tornabene; Carolina Iodice; Feliciano Visconte; Annamaria Carissimo; Diego Luis Medina; Gabriella Castoria; Alberto Auricchio
Journal:  Hum Gene Ther       Date:  2018-07-05       Impact factor: 5.695

9.  A Comprehensive Map of CNS Transduction by Eight Recombinant Adeno-associated Virus Serotypes Upon Cerebrospinal Fluid Administration in Pigs.

Authors:  Nicolina Cristina Sorrentino; Veronica Maffia; Sandra Strollo; Vincenzo Cacace; Noemi Romagnoli; Anna Manfredi; Domenico Ventrella; Francesco Dondi; Francesca Barone; Massimo Giunti; Anne-Renee Graham; Yan Huang; Susan L Kalled; Alberto Auricchio; Maria Laura Bacci; Enrico Maria Surace; Alessandro Fraldi
Journal:  Mol Ther       Date:  2015-12-07       Impact factor: 11.454

10.  Challenging Safety and Efficacy of Retinal Gene Therapies by Retinogenesis.

Authors:  Elena Marrocco; Rosa Maritato; Salvatore Botta; Marianna Esposito; Enrico Maria Surace
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.